OR-RADISYS
17.12.2020 14:02:14 CET | Business Wire | Press release
Radisys® Corporation , a global leader of open telecom solutions, today announced that ContactMakers , a contact center telephony solutions and customer care provider, has selected Radisys Engage Media Server as the foundation for its VOIP Communication ContactSuite platform as it moves the solution to the cloud. The Engage Media Server’s extensive flexible capabilities enable ContactMakers to focus its resources to add unique applications, enhanced user experience and custom capabilities for its unique customer interaction suite, rather than on the communications infrastructure. ContactMakers will be able to use the media server to address specific customer requirements more quickly, while reducing costs and complexity by utilizing a common media processing platform for advanced voice, video, media analytics, and other capabilities for its customer offerings.
Highlights
- Customer contact is always critical to business. Despite the evolution and expansion of communication channels including the internet, text messaging and social media, telecommunications access solutions like business VOIP, mobile and landlines continue to anchor a high volume of interactions including the most critical customer care interactions.
- With today’s fluid workforce, dynamic global conditions and a growing trend toward remote customer interactions, having a reliable media foundation for real-time voice and video sessions is more critical than ever. To meet this challenge, businesses need a contact center solution that enables them to bring new, scalable and elastic services online more quickly and that can be adapted to changing market conditions more easily than existing off-the-shelf Customer Communication-as-a-Service (CCaaS) products.
- ContactMakers is undertaking a telco-to-the-cloud migration of its proprietary communications application and interaction platform which it has built and optimized for clients’ customer communication requirements for more than 15 years. Leveraging Radisys Engage Media Server’s cloud-native platform, ContactMakers will be able to lower the cost of migration, deliver greater flexibility, and provide optimal resource utilization.
- ContactMakers will use the Engage Media Server to deliver telco-grade reliability, video, speech processing, biometrics, and high-quality voice capabilities as the anchor for its service platform.
- Radisys Engage Media Server is the industry’s leading real-time media processing platform that provides voice, video, and AI-based media, delivering a complete solution set for developers, CCaaS providers and Communications Service Providers (CSP) to create a wholistic digital customer engagement experience.
-
Customer Care, Unified Communications (UC) and CCaaS providers, including OEM and managed service providers alike, depend on Radisys for high quality, cloud-based media processing that can meet dynamic customer, market, and employee conditions, while providing a future-proof, market leading solutions including:
- Cloud scalability for broader market reach for digital experience applications and services at attractive price points
- Highest quality voice and video processing
- Support for VOIP, mobile and landline customer and employee connections
- Telco-grade reliability to ensure “always on” communications
“We have had a long relationship with Radisys to deliver high-quality communication services that our customers expect. Now, with Radisys’ help, we are able to seamlessly transition to a software environment that can run in our private data center or in the cloud,” said Denise Konings, CEO, ContactMakers. “The combination of Radisys technology, its consultative expertise in the rapidly evolving communications and mobile technology domain, and its world-class global support make Radisys not only a technology supplier, but our key partner in delivering high quality, engaging, customer interactions.”
“Reliable, scalable and cloud-based media processing is the foundation for delivering memorable customer interactions,” said Shankar Krishnamurthy, Radisys’ Senior Director, Business Development. “Engage Media Server is enabling ContactMakers to migrate its services to the cloud to better manage communication workflows, improve the user experience, and track critical customer and employee key performance indicators. It also allows ContactMakers to continue to focus its specialized resources and development budget on service applications.”
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital end points, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com .
About ContactMakers
ContactMakers facilitates and realizes top-level telephony for companies that go for quality in customer service. Superior communication technology in the cloud combined with people skills, passion and drive. ContactMakers inspires and challenges you to make every customer contact moment the best that it can be. Together we'll optimize every phase of the customer experience cycle. Visit www.contactmakers.nl for more information.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005338/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
